Famotidine is primarily indicated in conditions like Benign gastric and duodenal ulceration, Benign gastric ulcer, Duodenal ulceration, Duodenal ulcer, Duodenal ulcer relapse prophylaxis, Reflux oesophagitis, Zollinger-ellison syndrome, and can also be given in adjunctive therapy as an alternative drug of choice in Dyspepsia, Heart burn.
Famotidine produces potentially life-threatening effects which include Blood dyscrasias. which are responsible for the discontinuation of Famotidine therapy. The signs and symptoms that are produced after the acute overdosage of Famotidine include Hypotension, Tachycardia, Emesis, Restlessness. The symptomatic adverse reactions produced by Famotidine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Diarrhea, Constipation, Bradycardia, Jaundice, Mental confusion, Hypotension, Renal failure, Epidermal necrolysis.